TABLE OF CONTENTS
Volume 59, Issue S78 (February 2001)
Asymmetric Dimethylarginine |
Advanced Glycation End Products |
Inhibitors of Erythropoiesis |
Guanidino Compounds in Uremia |
Oxidative Modifications And Carbamoylation of Amino Acids And Proteins in Uremia |
2-microglobulin | Parathyroid Hormone, Vitamin D, Calcium And Phosphorus |
Cellular Immune Defects in Uremia |
Hyperhomocysteinemia in Uremia |
Effect of Uremic Toxins in Various Clinical Conditions |
Impact of Dialysis Therapies on Uremic Toxins
Introduction
Introduction FREE
Gere Sunder-Plassmann Guest Editor and Walter H Hörl Guest Editor
Kidney Int 59: S1-S1; doi:10.1046/j.1523-1755.2001.59780001.x
Asymmetric Dimethylarginine
Urea-induced inducible nitric oxide synthase inhibition and macrophage proliferation FREE
THOMAS MOESLINGER and PAUL GERHARD SPIECKERMANN
Kidney Int 59: S2-S8; doi:10.1046/j.1523-1755.2001.59780002.x
Relationship of asymmetric dimethylarginine to dialysis treatment and atherosclerotic disease FREE
JAN T KIELSTEIN, STEFANIE M BODE-BÖGER, JÜRGEN C FRÖLICH, HERMANN HALLER and RAINER H BÖGER
Kidney Int 59: S9-S13; doi:10.1046/j.1523-1755.2001.59780009.x
Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients FREE
CHRISTIAN FLECK, ALEXANDER JANZ, FRANK SCHWEITZER, ELKE KARGE, MARKUS SCHWERTFEGER and GÖNTER STEIN
Kidney Int 59: S14-S18; doi:10.1046/j.1523-1755.2001.59780014.x
Increased reduction of dimethylarginines and lowered interdialytic blood pressure by the use of biocompatible membranes FREE
MATTHIAS SCHRÖDER, EBERHARD RIEDEL, WERNER BECK, REINHOLD M DEPPISCH and WOLFGANG POMMER
Kidney Int 59: S19-S24; doi:10.1046/j.1523-1755.2001.59780019.x
Advanced Glycation End Products
Reactive carbonyl compounds related uremic toxicity ("carbonyl stress") FREE
TOSHIO MIYATA, SATOSHI SUGIYAMA, AKIRA SAITO and KIYOSHI KUROKAWA
Kidney Int 59: S25-S31; doi:10.1046/j.1523-1755.2001.59780025.x
Inflammation and advanced glycation end products in uremia: Simple coexistence, potentiation or causal relationship? FREE
SUSANNE SCHWEDLER, REINHARD SCHINZEL, PETER VAITH and CHRISTOPH WANNER
Kidney Int 59: S32-S36; doi:10.1046/j.1523-1755.2001.59780032.x
3-Deoxyglucosone and AGEs in uremic complications: Inactivation of glutathione peroxidase by 3-deoxyglucosone FREE
TOSHIMITSU NIWA and SAORI TSUKUSHI
Kidney Int 59: S37-S41; doi:10.1046/j.1523-1755.2001.59780037.x
Peritoneal sclerosis in peritoneal dialysis patients related to dialysis settings and peritoneal transport properties FREE
JOERG PLUM, SWETLANA HERMANN, ANDREAS FUSSHÖLLER, GERRIT SCHOENICKE, ANDREAS DONNER, ANSGAR RÖHRBORN and BERND GRABENSEE
Kidney Int 59: S42-S47; doi:10.1046/j.1523-1755.2001.59780042.x
Uremic toxins modulate the spontaneous apoptotic cell death and essential functions of neutrophils FREE
GERALD COHEN, MICHAEL RUDNICKI and WALTER H HÖORL
Kidney Int 59: S48-S52; doi:10.1046/j.1523-1755.2001.59780048.x
Advanced glycation end products impair protein turnover in LLC-PK1: Amelioration by trypsin FREE
GUANGSHENG XIANG, REINHARD SCHINZEL, ANDREAS SIMM, KATARINA SEBEKOVA and AUGUST HEIDLAND
Kidney Int 59: S53-S57; doi:10.1046/j.1523-1755.2001.59780053.x
Circulating advanced glycation end product levels in rats rapidly increase with acute renal failure FREE
KATARÍNA 
SEBEKOVÁ, PAVOL BLA
Í
EK, DAGMAR SYROVÁ, ZORA KRIVOÍKOVÁ, VIERA SPUSTOVÁ, AUGUST HEIDLAND and REINHARD SCHINZEL
Kidney Int 59: S58-S62; doi:10.1046/j.1523-1755.2001.59780058.x
Differences in the modulating potential of advanced glycation end product (AGE) peptides versus AGE proteins FREE
WINNIE DEUTHER-CONRAD, SYBILLE FRANKE, MANFRED SOMMER, THOMAS HENLE and GÜNTER STEIN
Kidney Int 59: S63-S66; doi:10.1046/j.1523-1755.2001.59780063.x
Inhibitors of Erythropoiesis
Role of uremic toxins in exacerbating anemia in renal failure FREE
IAIN C MACDOUGALL
Kidney Int 59: S67-S72; doi:10.1046/j.1523-1755.2001.59780067.x
Polymeric protein-polyamine conjugates: A new class of uremic toxins affecting erythropoiesis FREE
FRANCESCO GALLI, SIMONE BENINATI, SERENA BENEDETTI, ALESSANDRO LENTINI, FRANCO CANESTRARI, ANTONIO TABILIO and UMBERTO BUONCRISTIANI
Kidney Int 59: S73-S76; doi:10.1046/j.1523-1755.2001.59780073.x
Guanidino Compounds in Uremia
Endogenous guanidino compounds as uremic neurotoxins FREE
PETER P DE DEYN, RUDI D'HOOGE, PIERRE-PAUL VAN BOGAERT and BART MARESCAU
Kidney Int 59: S77-S83; doi:10.1046/j.1523-1755.2001.59780077.x
Characterization of p-hydroxy-hippuric acid as an inhibitor of Ca2+-ATPase in end-stage renal failure FREE
JOACHIM JANKOWSKI, MARTIN TEPEL, NINA STEPHAN, MARKUS VAN DER GIET, VERA BREDEN, WALTER ZIDEK and HARTMUT SCHLÜTER
Kidney Int 59: S84-S88; doi:10.1046/j.1523-1755.2001.59780084.x
Uremic concentrations of guanidino compounds inhibit neutrophil superoxide production FREE
AKI HIRAYAMA, ALBERTO A NORONHA-DUTRA, MICHAEL P GORDGE, GUY H NEILD and JOHN S HOTHERSALL
Kidney Int 59: S89-S92; doi:10.1046/j.1523-1755.2001.59780089.x
Role of nitric oxide in the synthesis of guanidinosuccinic acid, at activator of the N-methyl-D-asparate receptor FREE
KAZUMASA AOYAGI, SIRANOUSH SHAHRZAD, SATOMI IIDA, CHIE TOMIDA, AKI HIRAYAMA, SOHJI NAGASE, KATSUMI TAKEMURA, AKIO KOYAMA, SHOJI OHBA, MITSUHARU NARITA and BURTON D COHEN
Kidney Int 59: S93-S96; doi:10.1046/j.1523-1755.2001.59780093.x
Erythrocyte transketolase activity and guandino compounds in hemodialysis patients FREE
IRENA PIETRZAK and KAZIMIERZ BACZYK
Kidney Int 59: S97-S101; doi:10.1046/j.1523-1755.2001.59780097.x
Oxidative Modifications And Carbamoylation of Amino Acids And Proteins in Uremia
Carbamoylation of amino acids and proteins in uremia FREE
LORRAINE M KRAUS and ALFRED P KRAUS JR
Kidney Int 59: S102-S107; doi:10.1046/j.1523-1755.2001.59780102.x
Importance of oxidatively modified proteins in chronic renal failure FREE
BÉATRICE DESCAMPS-LATSCHA and VÉRONIQUE WITKO-SARSAT
Kidney Int 59: S108-S113; doi:10.1046/j.1523-1755.2001.59780108.x
Role of oxidized low-density lipoprotein in the atherosclerosis of uremia FREE
TILMAN B DRÜEKE, THAO NGUYEN KHOA, ZIAD A MASSY, VÉRONIQUE WITKO-SARSAT, BERNARD LACOUR and BÉATRICE DESCAMPS-LATSCHA
Kidney Int 59: S114-S119; doi:10.1046/j.1523-1755.2001.59780114.x
Dual effect of oxidized LDL on cell cycle in human endothelial cells through oxidative stress FREE
JAN GALLE, ALEXANDRA HEINLOTH, CHRISTOPH WANNER and KATHRIN HEERMEIER
Kidney Int 59: S120-S123; doi:10.1046/j.1523-1755.2001.59780120.x
Insulin and heparin suppress superoxide production in diabetic rat glomeruli stimulated with low-density lipoprotein FREE
HUNG-CHUN CHEN, JINN-YUH GUH, SHYI-JANG SHIN, JUEI-HSIUNG TSAI and YUNG-HSIUNG LAI
Kidney Int 59: S124-S127; doi:10.1046/j.1523-1755.2001.59780124.x
Ex vivo low-density lipoprotein oxidizability and in vivo lipid peroxidation in patients on CAPD FREE
JOHANNES M ROOB, THOMAS RABOLD, MARIANNE HAYN, GHOLAMALI KHOSCHSORUR, ULRIKE RESCH, HERWIG HOLZER and BRIGITTE M WINKLHOFER-ROOB
Kidney Int 59: S128-S136; doi:10.1046/j.1523-1755.2001.59780128.x
Effects of a vitamin E-modified dialysis membrane on neutrophil superoxide anion radical production FREE
TAKEKAZU SHIMAZU, MASAYUKI OMINATO, KATSUHIDE TOYAMA, TAKASHI YASUDA, TAKEO SATO, TERUHIKO MAEBA, SHIGERU OWADA and MASASHI ISHIDA
Kidney Int 59: S137-S143; doi:10.1046/j.1523-1755.2001.59780137.x
A modified dialyzer with vitamin E and antioxidant defense parameters FREE
MIROSLAV MYDLÍK, KATARÍNA DERZSIOVÁ, OLIVER RÁCZ, ANNA IPULOVÁ, EVA LOVÁSOVÁ and JOZEFÍNA PETROVIOVÁ
Kidney Int 59: S144-S147; doi:10.1046/j.1523-1755.2001.59780144.x
Vitamin E, lipid profile, and peroxidation in hemodialysis patients FREE
FRANCESCO GALLI, ZSUZSA VARGA, JOZSEF BALLA, BARBARA FERRARO, FRANCO CANESTRARI, ARDESIO FLORIDI, GYORGY KAKUK and UMBERTO BUONCRISTIANI
Kidney Int 59: S148-S154; doi:10.1046/j.1523-1755.2001.59780148.x
Glutathionyl hemoglobin in uremic patients undergoing hemodialysis and continuous ambulatory peritoneal dialysis FREE
FUMIO TAKAYAMA, SHUICHI TSUTSUI, MASANOBU HORIE, KAORU SHIMOKATA and TOSHIMITSU NIWA
Kidney Int 59: S155-S158; doi:10.1046/j.1523-1755.2001.59780155.x
Oxidative stress during hemodialysis: Effect of heparin FREE
SHIFRA SELA, REVITAL SHURTZ-SWIRSKI, GALINA SHAPIRO, LUBNA NASSER, MUNIR HAMZI, SHAUL M SHASHA and BATYA KRISTAL
Kidney Int 59: S159-S163; doi:10.1046/j.1523-1755.2001.59780159.x
2-microglobulin
2-Microglobulin–derived amyloidosis: An update FREE
JÜRGEN FLOEGE and MARKUS KETTELER
Kidney Int 59: S164-S171; doi:10.1046/j.1523-1755.2001.59780164.x
Dialysis-related amyloidosis of the heart in long-term hemodialysis patients FREE
FUMIO TAKAYAMA, SHIGERU MIYAZAKI, TAKASHI MORITA, YOSHIHEI HIRASAWA and TOSHIMITSU NIWA
Kidney Int 59: S172-S176; doi:10.1046/j.1523-1755.2001.59780172.x
Expression of 2-microglobulin and c-fos mRNA: Is there an influence of high- or low-flux dialyzer membranes? FREE
CHRISTOPH C HAUFE, ULRIKE EISMANN, REINHOLD M DEPPISCH and GÜNTER STEIN
Kidney Int 59: S177-S181; doi:10.1046/j.1523-1755.2001.59780177.x
Parathyroid Hormone, Vitamin D, Calcium And Phosphorus
Blunted response to vitamin D in uremia FREE
GRIET GLORIEUX and RAYMOND VANHOLDER
Kidney Int 59: S182-S185; doi:10.1046/j.1523-1755.2001.59780182.x
Defects in B-cell function and metabolism in uremia: Role of parathyroid hormone FREE
MIROSLAW SMOGORZEWSKI and SHAUL G MASSRY
Kidney Int 59: S186-S189; doi:10.1046/j.1523-1755.2001.59780186.x
Phosphate removal and hemodialysis conditions FREE
ROBERT POHLMEIER and JÖRG VIENKEN
Kidney Int 59: S190-S194; doi:10.1046/j.1523-1755.2001.59780190.x
Cellular Immune Defects in Uremia
Dysfunction of polymorphonuclear leukocytes in uremia: Role of parathyroid hormone FREE
SHAUL G MASSRY and MIROSLAW SMOGORZEWSKI
Kidney Int 59: S195-S196; doi:10.1046/j.1523-1755.2001.59780195.x
Apoptosis of leukocytes: Basic concepts and implications in uremia FREE
BERTRAND L JABER, MIGUEL CENDOROGLO, VAIDYANATHAPURAM S BALAKRISHNAN, MARY C PERIANAYAGAM, ANDREW J KING and BRIAN J G PEREIRA
Kidney Int 59: S197-S205; doi:10.1046/j.1523-1755.2001.59780197.x
Molecular aspects of T – and B-cell function in uremia FREE
MATTHIAS GIRNDT, MARTINA SESTER, URBAN SESTER, HARALD KAUL and HANS KÖHLER
Kidney Int 59: S206-S211; doi:10.1046/j.1523-1755.2001.59780206.x
DNA damage of lymphocytes in experimental chronic renal failure: Beneficial effects of losartan FREE
ZORA KRIVOÍKOVÁ, MÁRIA DUINSKÁ, VIERA SPUSTOVÁ, KATARÍNA EBEKOVÁ, PAVOL BLAÍEK, AUGUST HEIDLAND and RASTISLAV DZÚRIK
Kidney Int 59: S212-S215; doi:10.1046/j.1523-1755.2001.59780212.x
Complement-dependent acceleration of apoptosis in neutrophils by dialyzer membranes FREE
ALEXANDER R ROSENKRANZ, ELISABETH PEHERSTORFER, GÜNTHER F KÖRMÖCZI, GERHARD J ZLABINGER, GERT MAYER, WALTER H HÖRL and RAINER OBERBAUER
Kidney Int 59: S216-S220; doi:10.1046/j.1523-1755.2001.59780216.x
Hyperhomocysteinemia in Uremia
The folate cycle and disease in humans FREE
BRIAN FOWLER
Kidney Int 59: S221-S229; doi:10.1046/j.1523-1755.2001.59780221.x
Homocysteine and transmethylations in uremia FREE
ALESSANDRA F PERNA, DIEGO INGROSSO, PASQUALE CASTALDO, PATRIZIA GALLETTI and NATALE G DE SANTO
Kidney Int 59: S230-S233; doi:10.1046/j.1523-1755.2001.59780230.x
Homocysteine metabolism in renal failure FREE
COEN VAN GULDENER, FRANK STAM and COEN D A STEHOUWER
Kidney Int 59: S234-S237; doi:10.1046/j.1523-1755.2001.59780234.x
Recent insights into the molecular genetics of the homocysteine metabolism FREE
MANUELA FÖDINGEER, OSWALD F WAGNER, WALTER H HÖRL and GERE SUNDER-PLASSMANN
Kidney Int 59: S238-S242; doi:10.1046/j.1523-1755.2001.59780238.x
Homocyst(e)ine, oxidative stress, and endothelium function in uremic patients FREE
ZIAD A MASSY, IRÈNE CEBALLOS, BERNADETTE CHADEFAUX-VEKEMENS, THAO NGUYEN-KHOA, BEATRICE DESCAMPS-LATSCHA, TILMAN B DRÜEKE and PAUL JUNGERS
Kidney Int 59: S243-S245; doi:10.1046/j.1523-1755.2001.59780243.x
Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients FREE
ANDREW G BOSTOM, DOUGLAS SHEMIN, REGINALD Y GOHH, ANDREW J BEAULIEU, PAMELA BAGLEY, ZIAD A MASSY, PAUL F JACQUES, LANCE DWORKIN and JACOB SELHUB
Kidney Int 59: S246-S252; doi:10.1046/j.1523-1755.2001.59780246.x
Effect of MTHFR genotypes and hyperhomocysteinemia on patient and graft survival in kidney transplant recipients FREE
WOLFGANG HAGEN, MANUELA FÖDINGER, GOTFRIED HEINZ, HEIDI BUCHMAYER, WALTER H HÖRL and GERE SUNDER-PLASSMANN
Kidney Int 59: S253-S257; doi:10.1046/j.1523-1755.2001.59780253.x
Is there a role of cyclosporine A on total homocysteine export from human renal proximal tubular epithelial cells? FREE
MIHAELA C IGNATESCU, MANUELA FÖDIGER, JOSEF KLETZMAYR, CHRISTIAN BIEGLMAYER, WALTER H HÖRL and GERE SUNDER-PLASSMANN
Kidney Int 59: S258-S261; doi:10.1046/j.1523-1755.59.s78.1.x
Homocysteine, its metabolites, and B-group vitamins in renal transplant patients FREE
GÜNTER STEIN, ANDREAS MÜLLER, MARTIN BUSCH, CHRISTIAN FLECK and HEIDE SPERSCHNEIDER
Kidney Int 59: S262-S265; doi:10.1046/j.1523-1755.2001.59780262.x
Effect of Uremic Toxins in Various Clinical Conditions
Protein-bound uremic solutes: The forgotten toxins FREE
RAYMOND VANHOLDER, RITA DE SMET and NORBERT LAMEIRE
Kidney Int 59: S266-S270; doi:10.1046/j.1523-1755.2001.59780266.x
Complement components as uremic toxins and their potential role as mediators of microinflammation FREE
REINHOLD M DEPPISCH, WERNER BECK, HERMANN GOEHL and EBERHARD RITZ
Kidney Int 59: S271-S277; doi:10.1046/j.1523-1755.2001.59780271.x
Hippurate participates in the correction of metabolic acidosis FREE
RASTISLAV DZÚRIK, VIERA SPUSTOVÁ, ZORA KRIVOÍKOVÁ and KATARÍNA GAZDÍKOVÁ
Kidney Int 59: S278-S281; doi:10.1046/j.1523-1755.2001.59780278.x
Impact of Dialysis Therapies on Uremic Toxins
Effects of dialyzer membrane on interleukin-1 (IL-1) and IL-1—converting enzyme in mononuclear cells FREE
SILVIA LINNENWEBER and GERHARD LONNEMANN
Kidney Int 59: S282-S285; doi:10.1046/j.1523-1755.2001.59780282.x
Does convective dialysis therapy applied daily approach renal blood purification? FREE
INGRID LEDEBO
Kidney Int 59: S286-S291; doi:10.1046/j.1523-1755.2001.59780286.x
Uremic toxins and peritoneal dialysis FREE
NORBERT LAMEIRE, RAYMOND VANHOLDER and RITA DE SMET
Kidney Int 59: S292-S297; doi:10.1046/j.1523-1755.2001.59780292.x
Renal versus continuous versus intermittent therapies for removal of uremic toxins FREE
WILLIAM R CLARK and LEE W HENDERSON
Kidney Int 59: S298-S303; doi:10.1046/j.1523-1755.2001.59780298.x
Renal replacement therapy and secondary hyperoxalemia in chronic renal failure FREE
MIROSLAV MYDLÍK and KATARÍNA DERZSIOVÁ
Kidney Int 59: S304-S307; doi:10.1046/j.1523-1755.2001.59780304.x
